Halozyme Therapeutics Inc. could earn up to $47 million in its latest deal with Baxter International Inc., which aims to develop a subcutaneous version of Gammagard, Baxter's intravenous immune ...
If you have an immunodeficiency related to certain infections, inflammatory diseases, or autoimmune disorders, you may have heard about an infusion treatment called intravenous immunoglobulin, or IVIG ...
Intravenous immunoglobulin (IVIg) is a treatment that can boost antibody levels in people with immunodeficiencies, autoimmune diseases, or inflammatory conditions. It contains antibodies, which are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results